Fifth Era Acquisition Corp I

Current report

Risks Related to the Miotal Business Combination and the Company

Current report

If the conditions to Closing (as defined in the Miotal Business Combination Agreement) in the Miotal Business Combination Agreement are not met, the Miotal Business Combination may not occur.

Current report

Even if our and Miotal’s shareholders approve the Miotal Business Combination, additional specified conditions must be satisfied or waived before the parties to the Miotal Business Combination Agreement are obligated to complete the Miotal Business Combination. We and Miotal may not satisfy all of the closing conditions in the Miotal Business Combination Agreement. If the closing conditions are not satisfied or waived, the Miotal Business Combination will not occur, or will be delayed pending later satisfaction or waiver, and such delay may cause us and Miotal to each lose some or all of the intended benefits of the Miotal Business Combination.

Current report

The Sponsor has entered into support agreements with us to vote in favor of the Miotal Business Combination.

Current report

Unlike some other blank check companies in which the initial shareholders agree to vote their Founder Shares in accordance with the majority of the votes cast by the Public Shareholders in connection with an initial business combination, the Sponsor, pursuant to the Sponsor Support Agreement, has agreed, among other things, to pay specified FERA Transaction Costs and vote in favor of the Miotal Business Combination and the transactions contemplated thereby (including the Merger).

Current report

Neither our board of directors nor any committee thereof obtained a third-party valuation in determining whether or not to pursue the Miotal Business Combination.

Current report

Neither board of directors nor any of its committees is required to obtain an opinion from an independent investment banking or accounting firm that the price that we are paying for Miotal is fair to our shareholders from a financial point of view. Neither our board of directors nor any of its committees obtained a third party valuation in connection with the Miotal Business Combination. The Company Board and management concluded that the Miotal Business Combination was in the best interest of our shareholders and that the valuation was appropriate based on qualitative factors and quantitative factors that were determined appropriate by our board of directors and management. Accordingly, investors will be relying solely on the judgment of our board of directors and management in valuing Miotal, and our board of directors and management may not have properly valued Miotal’s business or valued Miotal differently than either a third-party valuation firm or any particular investor. The lack of a third-party valuation may also lead an increased number of shareholders to demand redemption of their shares, which could potentially impact our ability to consummate the Miotal Business Combination or reduce the public float and therefore liquidity of the public trading market.

Current report

There are risks to Company shareholders becoming shareholders of Holdco through the Miotal Business Combination rather than acquiring securities of Miotal directly in an underwritten public offering, including no independent due diligence review by an underwriter and conflicts of interest of the Sponsor and its affiliates.

Current report

Because there is no independent third-party underwriter involved in the Miotal Business Combination or the issuance of Holdco Ordinary Shares in connection with the Miotal Business Combination, holders of Ordinary Shares and Rights will not receive the benefit of any outside independent review of our and Miotal’s respective finances and operations.

Current report

In a traditional underwritten public offering, an issuer initially sells its securities to the public market via one or more underwriters, who purchase such securities on a firm commitment basis and distribute or resell them to the public. Investors in such an offering benefit from the role played by underwriters. Underwriters have liability under the U.S. securities laws for material misstatements or omissions in a registration statement pursuant to which an issuer sells securities in an underwritten offering. Because the underwriters have a “due diligence” defense to such liability by, among other things, conducting a reasonable investigation, the underwriters and their counsel conduct a due diligence investigation of the issuer as part of the underwriting process. Due diligence entails engaging legal, financial and other experts to perform an investigation as to the accuracy of an issuer’s disclosure regarding, among other things, its business and financial results. Auditors of the issuer will also deliver a “comfort” letter to the underwriters with respect to the financial information contained in the registration statement. In making their investment decision, investors in an underwritten public offering have the benefit of such diligence.

Current report

While sponsors, private investors and management in a business combination involving a special purpose acquisition company like ours conduct due diligence on the target company, it is not necessarily the same level of due diligence undertaken by an underwriter in a public securities offering and, therefore, there could be a heightened risk of an incorrect valuation of Miotal’s business or material misstatements or omissions in the proxy statement/prospectus to be filed in connection with the business combination.

Current report

In addition, because there are no underwriters engaged in connection with the Miotal Business Combination, prior to the opening of trading on the Nasdaq on the trading day immediately following the closing of the Miotal Business Combination, there will be no traditional “roadshow” or book building process, and no price at which underwriters initially sold shares to the public to help inform efficient and sufficient price discovery with respect to the initial post-closing trades on the Nasdaq. Therefore, buy and sell orders submitted prior to and at the opening of initial post-closing trading of the Holdco Ordinary Shares will not have the benefit of being informed by a published price range or a price at which the underwriters initially sold shares to the public, as would be the case in an underwritten initial public offering.

Current report

There will be no underwriters assuming risk in connection with an initial resale of Holdco’s Ordinary Shares or helping to stabilize, maintain or affect the public price of Holdco Ordinary Shares following the closing of the Miotal Business Combination. Moreover, none of us, Miotal, nor Holdco will engage in, and has not and will not, directly or indirectly, request financial advisors to engage in, any special selling efforts or stabilization or price support activities in connection with the Holdco Ordinary Shares that will be outstanding immediately following the closing of the Miotal Business Combination. In addition, since Miotal will become public through a merger with a special purpose acquisition company, securities analysts of major brokerage firms may not provide coverage of Holdco since there is no incentive to brokerage firms to recommend the purchase of Holdco Ordinary Shares. No assurance can be given that brokerage firms will, in the future, want to conduct any offerings on behalf of Holdco. All of these differences from an underwritten public offering of Holdco Ordinary Shares could result in a more volatile price for such Holdco Ordinary Shares.

Current report

Such differences from an underwritten public offering may present material risks to unaffiliated investors that would not exist if Miotal became a publicly listed company through an underwritten initial public offering instead of upon completion of the Miotal Business Combination.

Current report

Our Initial Shareholders, including our Sponsor and our directors and executive officers, have interests that may conflict with the interests of our shareholders, and accordingly, a conflict of interest may have existed in determining whether the Miotal Business Combination is appropriate as our initial business combination.

Current report

Shareholders should keep in mind that the Sponsor and certain members of our board of directors and the Sponsor, including its directors and officers, have interests that are different from, or in addition to, those of our Public Shareholders generally and that these interests may conflict with the interests of our Public Shareholders.

Current report

The personal and financial interests of our Sponsor and our directors and officers may have influenced their motivation in identifying and selecting Miotal as a business combination target and completing an initial business combination with Miotal. In addition, the personal and financial interests of our Sponsor and our directors and officers may have created a conflict of interest as they negotiated the terms, conditions and timing of the Miotal Business Combination and determined whether they were appropriate and in the best interest of our shareholders. Our shareholders should consider these interests as they evaluate the recommendations of our board of directors to vote for the proposals.

Current report

Our directors and executive officers may have a conflict of interest when determining whether to agree to changes to or waive provisions of the Miotal Business Combination Agreement.

Current report

In the period leading up to the closing of the Miotal Business Combination, events may occur that would require the amendment of the Miotal Business Combination Agreement or that we provide consents or waivers under the Miotal Business Combination Agreement. These could include changes in the course of Miotal’s business, a request by Miotal to undertake actions that would otherwise be prohibited by the terms of the Miotal Business Combination Agreement or the occurrence of other events that would have a material adverse effect on Miotal’s business and would entitle us to terminate the Miotal Business Combination Agreement. In any of these circumstances, we would have the discretion, acting through our board of directors, to grant its consent or to waive those rights. The existence of financial and personal interests of our directors and executive officers to consummate the Miotal Business Combination may result in these directors and officers having a conflict of interest between what may be best for us and our shareholders and what is in the self-interest of these directors and officers.

Current report

Miotal shareholders will have significant influence over Holdco after completion of the Miotal Business Combination.

Current report

Upon the completion of the Miotal Business Combination, Miotal shareholders will collectively own a super-majority of the outstanding Holdco Ordinary Shares. Some of these persons or entities may have interests different than yours. For example, because many of these shareholders purchased their shares at prices substantially below the price at which we sold Public Shares in our IPO, they may be more interested in selling Holdco to an acquirer than other investors or they may want Holdco to pursue strategies that deviate from the interests of other shareholders.

Current report

If third parties bring claims against us, the proceeds held in the Trust Account could be reduced and the per share redemption amount received by shareholders may be less than $10.00 per share (which was the offering price in the IPO).

Current report

Placing funds in the Trust Account may not protect those funds from third-party claims. Although we will seek to have all vendors, service providers (other than the independent registered public accounting firm), prospective target businesses or other entities with which we do business execute agreements waiving any right, title, interest or claim of any kind in or to any monies held in the Trust Account, there is no guarantee that they will execute these agreements or even if they execute these agreements that they would be prevented from bringing claims against the Trust Account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim against our assets, including the funds held in the Trust Account. If any third party refuses to execute an agreement waiving claims to the monies held in the Trust Account, our Management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if Management believes that the third party’s engagement would be significantly more beneficial to us than any alternative.

Current report

Additionally, if we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, the proceeds held in the Trust Account could be subject to applicable bankruptcy or insolvency law and may be included in our bankruptcy or insolvency estate and subject to the claims of third parties with priority over the claims of our shareholders. To the extent any bankruptcy or insolvency claims deplete the Trust Account, the per-share amount that our Public Shareholders would receive in connection with our liquidation may be reduced.

Current report

If we become subject to bankruptcy proceedings after distributing the proceeds in the Trust Account to our Public Shareholders, the bankruptcy court may seek to recover those proceeds.

Current report

If, after we distribute the proceeds in the Trust Account to our Public Shareholders, we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, any distributions that the Public Shareholders have received could be viewed under applicable debtor/creditor and/or bankruptcy or insolvency laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy or insolvency court could seek to recover some or all amounts received by our Public Shareholders. In addition, our board of directors may be viewed as having breached its fiduciary duty to our creditors and/or having acted in bad faith, thereby exposing us and our board of directors to claims of punitive damages, by paying Public Shareholders from the Trust Account prior to addressing the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons.

Current report

Additionally, the proceeds held in the Trust Account could be subject to applicable bankruptcy law and may be included in the bankruptcy estate and subject to the claims of third parties with priority over the claims of the shareholders. To the extent any bankruptcy claims deplete the Trust Account, the per share amount that would otherwise be received by the Public Shareholders in connection with our liquidation may be reduced.

Current report

Nasdaq may not agree to list Holdco’s securities on its exchange, which could limit investors’ ability to make transactions in Holdco’s securities and subject Holdco to additional trading restrictions.

Current report

An active trading market for Holdco’s securities following the Miotal Business Combination may never develop or, if developed, it may not be sustained. In connection with the Miotal Business Combination, in order to continue to maintain the listing of our securities on Nasdaq, we will be required to demonstrate compliance with Nasdaq’s listing requirements. We will apply to have Holdco’s securities listed on Nasdaq upon consummation of the Miotal Business Combination. It is not certain that Holdco will be able to meet all listing requirements. Even if Holdco’s securities are listed on Nasdaq, Holdco may be unable to maintain the listing of its securities in the future.

Current report

If Holdco fails to meet the listing requirements, and Nasdaq does not list its securities on its exchange, Miotal would not be required to consummate the Miotal Business Combination. In the event that Miotal elected to waive this condition, and the Miotal Business Combination were consummated without Holdco’s securities being listed on the Nasdaq or on another national securities exchange, Holdco could face significant material adverse consequences, including:

Current report

The National Securities Markets Improvement Act of 1996 (“NSMIA”), which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are listed on a stock exchange and referred to as “covered securities.” If Holdco’s securities were not listed on Nasdaq, such securities would not qualify as covered securities, and we would be subject to regulation in each state in which Holdco’s securities are offered because NSMIA does not preempt states from regulating the sale of securities that are not covered securities.

Current report

A Public Shareholder who wishes to redeem its Public Shares must comply with specific requirements for redemption that, if not complied with, may prevent that Public Shareholder from redeeming its Public Shares for a pro rata portion of the funds held in the Trust Account.

Current report

A Public Shareholder will be entitled to receive cash for any Public Shares to be redeemed only if it: (i) holds Public Shares; (ii) submits a written request to Continental, our transfer agent, in which it (a) requests that we redeem all or a portion of its Public Shares for cash, and (b) identifies itself as a beneficial holder of the Public Shares and provides its legal name, phone number and address; and (iii) delivers its Public Shares to Continental, our transfer agent, physically or electronically through the Depository Trust Company (“DTC”). Public Shareholders must complete the procedures for electing to redeem their Public Shares in the manner described above prior to 5:00 p.m., Eastern Time, two business days before the Company shareholders’ meeting, in order for their shares to be redeemed. In order to obtain a physical stock certificate, a shareholder’s broker and/or clearing broker, DTC and Continental will need to act to facilitate this request. It is our understanding that shareholders should generally allot at least two weeks to obtain physical certificates from the transfer agent. However, because we do not have any control over this process or over DTC, it may take significantly longer than two weeks to obtain a physical stock certificate. If it takes longer than anticipated to obtain a physical certificate, public shareholders who wish to redeem their Public Shares may be unable to obtain physical certificates by the deadline for exercising their redemption rights and thus will be unable to redeem their shares.

Current report

If the Miotal Business Combination is consummated, and if a Public Shareholder properly exercises its right to redeem all or a portion of the Public Shares that it holds and timely delivers its shares to Continental, our transfer agent, we will redeem those Public Shares for a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the Miotal Business Combination, including any interest earned on the Trust Account deposits (which interest shall be net of taxes payable), divided by the number of then-outstanding Public Shares, subject to certain limitations.

Current report

If a Public Shareholder fails to receive notice of our offer to redeem Public Shares in connection with the Miotal Business Combination or fails to comply with the procedures for tendering its shares, its shares may not be redeemed.

Current report

If, despite our compliance with the proxy rules, a Public Shareholder fails to receive our proxy materials, such Public Shareholder may not become aware of the opportunity to redeem its Public Shares. In addition, the proxy materials that we are furnishing to holders of Company Ordinary Shares in connection with the Miotal Business Combination describes the various procedures that must be complied with in order to validly redeem the Public Shares. In the event that a Public Shareholder fails to comply with these procedures, its Public Shares may not be redeemed.

Current report

We do not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete the Miotal Business Combination even if a substantial majority of our shareholders do not support it.

Current report

Our Amended and Restated Articles do not provide a specified maximum redemption threshold. In addition, after the redemptions completed in connection with any amendment to our charter to extend our Combination Period, the Sponsor and independent directors collectively own a sufficient number of shares to approve the Miotal Business Combination without the approval of a majority of our Public Shareholders. As a result, we may be able to complete the Miotal Business Combination even though a substantial majority of the Public Shareholders do not agree with the transaction and have redeemed their shares or have entered into privately negotiated agreements to sell their shares to the Sponsor, directors, officers, advisors or their affiliates.

Current report

We can give no assurance as to the price at which a shareholder may be able to sell its Holdco Ordinary Shares in the future following the completion of the Miotal Business Combination or any alternative business combination. Certain events following the consummation of any initial business combination, including the Miotal Business Combination, may cause an increase in Holdco’s share price, and may result in a lower value realized now than a shareholder of Holdco might realize in the future had the shareholder not redeemed its shares. Similarly, if a shareholder does not redeem its shares, the shareholder will bear the risk of ownership of the Holdco Ordinary Shares after the consummation of the Miotal Business Combination, and there can be no assurance that a shareholder can sell its shares in the future for a greater amount than the redemption price. A shareholder should consult its own financial advisor for assistance on how this may affect his, her or its individual situation.

Current report

If we do not complete this or another initial business combination by the Combination Period, we will cease all operations and wind up our business, in which case our Public Shareholders would only receive the available funds in the Trust Account and the Rights would expire worthless.